Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Apr;42(4):418-424.
doi: 10.1002/clc.23156. Epub 2019 Mar 15.

Comparisons of efficacy, safety, and recurrence risk factors of paroxysmal and persistent atrial fibrillation catheter ablation using robotic magnetic navigation system

Affiliations
Comparative Study

Comparisons of efficacy, safety, and recurrence risk factors of paroxysmal and persistent atrial fibrillation catheter ablation using robotic magnetic navigation system

Xiao-Xi Zhao et al. Clin Cardiol. 2019 Apr.

Abstract

Background: No data exist on comparisons of efficacy, safety, and recurrence risk factors of paroxysmal and persistent atrial fibrillation (AF) ablation using robotic magnetic navigation system (MNS), respectively.

Methods: About 151 AF patients were prospectively enrolled and divided into paroxysmal AF group (n = 102) and persistent AF group (n = 49). Circumferential pulmonary vein antrum isolation (CPVI) was performed in all patients. Linear ablation at the left atrial roof and mitral isthmus was performed in patients with persistent AF in addition to CPVI. The procedural time, X-ray exposure time, acute and long-term success rates of CPVI, and procedure-related complications were analyzed. The AF recurrence rates in the two groups were compared during 1 year, and Cox regression was used to analyze the recurrence risk factors.

Results: The acute success rates of CPVI in the two groups were 98.04% and 97.96%, respectively. There were no significant differences in the procedural time, X-ray exposure time, and ablation time between the two groups (P > 0.05). No serious complications appeared in either group. The AF ablation success rates were 70.6% and 57.1% for the paroxysmal and persistent groups respectively at 12-month follow-up (P = 0.102). AF duration and coronary heart disease prior to ablation were associated with the higher AF recurrence in patients with persistent AF.

Conclusion: Ablation using MNS is effective and safe both in patients with paroxysmal and persistent AF. AF duration and coronary heart disease prior to ablation are two independent risk factors of AF recurrence in patients with persistent AF postoperatively.

Keywords: atrial fibrillation; catheter ablation; magnetic navigation system; recurrence; risk factor.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to report.

Figures

Figure 1
Figure 1
Catheter ablation of paroxysmal (left) and persistent (right) atrial fibrillation using magnetic navigation system. Left panel is paroxysmal atrial fibrillation ablation using magnetic navigation system, and the ablation protocol is only circumferential pulmonary vein antrum isolation. Right panel is persistent atrial fibrillation ablation using magnetic navigation system, and the ablation protocol is the linear ablation of mitral isthmus and left atrial roof in addition to circumferential pulmonary vein antrum isolation. The upper panel and the lower panel in left and right are the pictures at the same time, but the upper panel can simultaneously show three‐dimensional model of left atrium and ablation lines on fluoroscopy monitor, and the lower panel only shows ablation lines on fluoroscopy monitor
Figure 2
Figure 2
Kaplan‐Meier curve of atrial fibrillation recurrence after ablation using magnetic navigation system. A Kaplan‐Meier analysis was used to compare the probability of atrial fibrillation recurrence between the two groups. The Kaplan‐Meier analysis showed that the incidences of freedom from atrial fibrillation were 70.6% and 57.1% in patients with paroxysmal atrial fibrillation and paroxysmal atrial fibrillation respectively after 12‐month follow‐up

Similar articles

Cited by

References

    1. Magnani JW, Rienstra M, Lin H, et al. Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation. 2011;124:1982‐1993. - PMC - PubMed
    1. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1‐e76. - PubMed
    1. Andrade JG, Macle L, Nattel S, Verma A, Cairns J. Contemporary atrial fibrillation management: a comparison of the current AHA/ACC/HRS, CCS, and ESC guidelines. Can J Cardiol. 2017;33:965‐976. - PubMed
    1. Maurer T, Sohns C, Deiss S, et al. Significant reduction in procedure duration in remote magnetic‐guided catheter ablation of atrial fibrillation using the third‐generation magnetic navigation system. J Interv Card Electrophysiol. 2017;49:219‐226. - PubMed
    1. Errahmouni A, Latcu DG, Bun SS, Rijo N, Dugourd C, Saoudi N. Remotely controlled steerable sheath improves result and procedural parameters of atrial fibrillation ablation with magnetic navigation. Europace. 2015;17:1045‐1050. - PMC - PubMed

Publication types

MeSH terms